Key Statistics
Market Cap$6.08B
P/E RatioN/A
Div. Yield—
EPS (TTM)-$1.03
52W High$53.19
52W Low$1.87
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees59
Price Performance
1 Week-0.38%
3 Month+34.52%
1 Year+2162.66%
FinancialsAnnual · QuiverQuant
Revenue$0
Assets$268.52M
Liabilities$13.15M
Net Income$90.21M loss
About
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of nonalcoholic steatohepatitis (NASH) and other chronic liver diseases. The company is headquartered in Foster City, California.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze TERN with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.